David M. Chascsa, M.D.

  1. Gastroenterologist
  2. Gastroenterologist (Transplant Hepatologist)
  3. Internist

Publicaciones

  1. Chascsa DMH, Lindor KD. Emerging therapies for PBC. J Gastroenterol. 2020 Mar; 55 (3):261-272 Epub 2020 Jan 22
    View PubMed
  2. Tang DM, Chascsa DM, Chou JY, Ho N, Auh S, Wank SA, Koh C, Kumar S. Helicobacter pylori infection is strongly associated with metabolic syndrome, and weakly associated with non-alcoholic fatty liver disease, in a US Hispanic population. GastroHep. 2019 Oct; 1(6).
  3. Chascsa DM, Lindor KD. Cancer risk, screening and surveillance in primary sclerosing cholangitis. Minerva Gastroenterol Dietol. 2019 Sep; 65 (3):214-228 Epub 2019 June 19
    View PubMed
  4. Lizaola-Mayo BC, Vargas HE, Chascsa DM. Hepatitis C-Positive Organs for Liver and Kidney Transplantation - Emerging Data and Current Management Strategies. Curr Hepatol Reports. 2019.
  5. Chascsa DM, Lai JC, Dunn MA, Montano-Loza AJ, Kappus MR, Dasarathy S, Carey EJ. Patient and Caregiver Attitudes and Practices of Exercise in Candidates Listed for Liver Transplantation. Dig Dis Sci. 2018 Dec; 63 (12):3290-3296 Epub 2018 Sept 03
    View PubMed
  6. DeLeon TT, Salomao MA, Aqel BA, Sonbol MB, Yokoda RT, Ali AH, Moss AA, Mathur AK, Chascsa DM, Rakela J, Bryce AH, Borad MJ. Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experience. J Gastrointest Oncol. 2018 Dec; 9 (6):1054-1062
    View PubMed
  7. Chascsa DM, Mousa OY, Chascsa DM, Mousa OY, Pungpapong S, Zhang N, Chervenak A, Zhang N, Chervenak A, Nidamanuri S, Rodriguez E, Franco D, Ryland K, Ryland K, Keaveny AP, Huskey JL, Smith M, Huskey JL, Smith M, Reddy KS, Taner CB, Vargas HE, Aqel BA. Clinical outcomes of hepatitis C treatment before and after kidney transplantation and its impact on time to transplant: A multicenter study. Am J Transplant. 2018 Oct; 18 (10):2559-2565 Epub 2018 June 08
    View PubMed
  8. Chascsa DM, Rakela J. Knowns and Unknowns: the Safety and Efficacy of Cancer Immunotherapy in Chronic Liver Disease. Curr Hepatology Rep. 2018; 17(3):153-155.
  9. Chascsa DM, Lindor KD. Antimitochondrial Antibody-Negative Primary Biliary Cholangitis: Is It Really the Same Disease? Clin Liver Dis. 2018 Aug; 22 (3):589-601
    View PubMed
  10. Chascsa DM, Vargas HE. The gastroenterologist's guide to management of the post-liver transplant patient. Am J Gastroenterol. 2018 Jun; 113 (6):819-828 Epub 2018 May 11
    View PubMed
  11. Chascsa D, Carey EJ, Lindor KD. Old and new treatments for primary biliary cholangitis. Liver Int. 2017 Apr; 37 (4):490-499
    View PubMed
  12. Ferre EM, Rose SR, Rosenzweig SD, Burbelo PD, Romito KR, Niemela JE, Rosen LB, Break TJ, Gu W, Hunsberger S, Browne SK, Hsu AP, Rampertaap S, Swamydas M, Collar AL, Kong HH, Lee CR, Chascsa D, Simcox T, Pham A, Bondici A, Natarajan M, Monsale J, Kleiner DE, Quezado M, Alevizos I, Moutsopoulos NM, Yockey L, Frein C, Soldatos A, Calvo KR, Adjemian J, Similuk MN, Lang DM, Stone KD, Uzel G, Kopp JB, Bishop RJ, Holland SM, Olivier KN, Fleisher TA, Heller T, Winer KK, Lionakis MS. Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. JCI Insight. 2016 Aug 18; 1: (13).
    View PubMed
  13. Mandell MS, Seres T, Lindenfeld J, Biggins SW, Chascsa D, Ahlgren B, Wachs M, Bambha KM. Risk factors associated with acute heart failure during liver transplant surgery: a case control study. Transplantation. 2015 Apr; 99: (4)873-8.
    View PubMed
PST-20358470